发明名称 Anti-cd38 antibodies
摘要 Disclosed is an isolated antibody which specifically binds human CD38 (SEQ ID NO: 1, as defined in the complete specification) and cynomolgus CD38 (SEQ ID NO: 2, as defined in the complete specification) comprising: a) a heavy chain variable region comprising: i) a first CDR comprising SEQ ID NO: 13 (GFTFNNYD); ii) a second CDR comprising SEQ ID NO: 14 (ISYDGSDK); iii) a third CDR comprising SEQ ID NO: 15 (ARVYYYGFSGPSMDV); and b) a light chain variable region comprising: i) a first CDR comprising SEQ ID NO: 16 (NSNIGSNT); ii) a second CDR comprising SEQ ID NO: 17 (SDS); iii) a third CDR comprising SEQ ID NO: 18 (QSYDSSLSGSR). Also disclosed is the use of said antibody in the manufacture of a medicament for the treatment of an auto immune disease.
申请公布号 NZ705848(A) 申请公布日期 2016.07.29
申请号 NZ20110705848 申请日期 2011.12.30
申请人 TAKEDA PHARMACEUTICAL COMPANY LIMITED 发明人 ELIAS KATHLEEN ANN;LANDES GREGORY;SINGH SHWETA;KORVER WOUTER;DRAKE ANDREW WALLING;HAAK-FRENDSCHO MARY;SNELL GYORGY PAL;BHASKAR VINAY
分类号 C07K16/28;A61P35/02 主分类号 C07K16/28
代理机构 代理人
主权项
地址
您可能感兴趣的专利